Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Effect And Safety Of Ziprasidone Compared To Other Atypical Antipsychotic Drug In Schizophrenic Patients

This study has been completed.
Sponsor:
Information provided by:
Pfizer
ClinicalTrials.gov Identifier:
NCT00159770
First received: September 8, 2005
Last updated: December 28, 2006
Last verified: December 2006
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Estimated Study Completion Date: September 2004
  Estimated Primary Completion Date: No date given